(firstQuint)Mucinex for Treatment of Filamentary Keratitis.

 The study is aimed to determine if oral administration of Mucinex(R) is effective in reducing the amount of corneal filaments and improving symptomology in subjects with filamentary keratitis.

 Subjects will be instructed to take 600 mg tablets of extended release Mucinex(R) twice a day (total dose is 1.

2 g/day) for 4 weeks.

.

 Mucinex for Treatment of Filamentary Keratitis@highlight

It is a pilot study aimed to determine if oral Mucinex(R) is effective in reducing the amount of corneal filaments and improving symptomology in subjects with filamentary keratitis.

